Tumor Clearance (Complete Response) in One Patient, Greater than 90% (Near Complete Response) in Second Patient, Greater than 50% (Partial Response) in Third ...
Research reveals IL-12 nanoparticles paired with checkpoint inhibitors can eradicate ovarian tumors, showcasing potential for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback